GE HEALTHCARE TECHNOLOGY (GEHC) Stock Earnings & Estimates
NASDAQ:GEHC - US36266G1076 - Common Stock
73.72 USD
-0.54 (-0.73%)
73.72 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 18.341B 4.30% | 19.552B 6.60% | 19.672B 0.61% | 20.87B 6.09% | 21.841B 4.65% | 22.868B 4.70% | 23.486B 2.70% | 23.772B 1.22% | 24.388B 2.59% | |
| EBITDA YoY % growth | 3.155B -7.75% | 3.045B -3.49% | 3.205B 5.25% | 3.535B 10.30% | 3.891B 10.07% | 4.166B 7.07% | 4.664B 11.95% | 4.759B 2.04% | N/A | |
| EBIT YoY % growth | 2.522B -9.77% | 2.435B -3.45% | 2.625B 7.80% | 3.037B 15.70% | 3.311B 9.02% | 3.649B 10.21% | 4.084B 11.92% | N/A | N/A | |
| Operating Margin | 13.75% | 12.45% | 13.34% | 14.55% | 15.16% | 15.96% | 17.39% | N/A | N/A | |
| EPS YoY % growth | N/A | 3.94 10.02% | 4.49 13.96% | 4.61 2.72% | 5.04 9.33% | 5.64 11.94% | 6.02 6.62% | 5.82 -3.22% | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.08 -5.32% | 1.42 -2.04% | 1.06 4.90% | 1.18 11.29% | 1.24 14.73% | 1.51 6.28% | 1.18 11.67% | 1.24 5.49% | 1.34 7.91% | 1.77 17.57% |
| Revenue Q2Q % growth | 5.181B 6.54% | 5.731B 7.75% | 5.128B 7.35% | 5.322B 6.29% | 5.361B 3.47% | 5.92B 3.30% | 5.475B 6.77% | 5.586B 4.96% | 5.653B 5.45% | 6.282B 6.11% |
| EBITDA Q2Q % growth | 881.63M -21.00% | 1.084B -21.51% | 864.56M 13.01% | 949.75M 1.25% | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 743.92M 10.05% | 935.97M 16.85% | 702.94M 11.76% | 770.5M 17.81% | 795.6M 6.95% | 988.24M 5.58% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.06 6.00% | 0.94 | 0.12 | 13.24% |
| Q1 2025 Q2Q % growth | 1.01 12.22% | 0.93 | 0.08 | 8.42% |
| Q4 2024 Q2Q % growth | 1.45 22.88% | 1.29 | 0.16 | 12.49% |
| Q3 2024 Q2Q % growth | 1.14 15.15% | 1.07 | 0.07 | 6.17% |
| Q2 2024 Q2Q % growth | 1.00 8.70% | 1.00 | 0.00 | 0.18% |
| Q1 2024 Q2Q % growth | 0.90 5.88% | 0.92 | -0.02 | -2.68% |
| Q4 2023 Q2Q % growth | 1.18 -9.92% | 1.09 | 0.09 | 8.08% |
| Q3 2023 Q2Q % growth | 0.99 | 0.91 | 0.08 | 8.23% |
| Q2 2023 Q2Q % growth | 0.92 | 0.89 | 0.03 | 3.67% |
| Q1 2023 Q2Q % growth | 0.85 | 0.81 | 0.04 | 5.15% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 5.007B 3.47% | 5.062B | -55M | -1.09% |
| Q1 2025 Q2Q % growth | 4.777B 2.73% | 4.757B | 20M | 0.42% |
| Q4 2024 Q2Q % growth | 5.319B 2.17% | 5.437B | -118M | -2.17% |
| Q3 2024 Q2Q % growth | 4.863B 0.85% | 4.966B | -103M | -2.07% |
| Q2 2024 Q2Q % growth | 4.839B 0.46% | 4.97B | -131M | -2.64% |
| Q1 2024 Q2Q % growth | 4.65B -1.21% | 4.897B | -247M | -5.04% |
| Q4 2023 Q2Q % growth | 5.206B 5.43% | 5.193B | 13M | 0.25% |
| Q3 2023 Q2Q % growth | 4.822B 5.38% | 4.901B | -79M | -1.61% |
| Q2 2023 Q2Q % growth | 4.817B -45.43% | 4.89B | -73M | -1.49% |
| Q1 2023 Q2Q % growth | 4.707B | 4.727B | -20M | -0.42% |
| Q4 2022 Q2Q % growth | 4.938B 7.61% | % | ||
| Q3 2022 Q2Q % growth | 4.576B 6.32% | % | ||
| Q2 2022 Q2Q % growth | 8.827B 1.55% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 12.47% | -12.54% | 10.98% | 11.59% |
| Revenue | 0.97% | 2.49% | 0.88% | 0.92% |